Are outcomes of giant ventral hernia repair inferior? A propensity-matched analysis.
Abstract
[BACKGROUND] Ventral hernia repair (VHR) of large defects poses significant technical challenges due to the size of the hernia and complexity of operative techniques required for fascial closure. This study examined clinical outcomes in "giant" open VHR (GVHR), with hernia defect size (HDS) ≥ 200 cm, versus "non-giant" open VHR (NGVHR) with HDS < 200 cm using a propensity-matched approach.
[METHODS] A prospectively-maintained database from a tertiary hernia center was reviewed for patients undergoing open VHR. 1:1 propensity-score matching was performed for GVHR versus NGVHR based on age, BMI, comorbidities, fascial defect closure, primary vs recurrent repair, CDC wound class, and ASA score. A multivariable regression model evaluated whether wound complications increased odds of recurrence. CDC class III/IV wounds and concomitant intraabdominal procedures were excluded. Standard statistical analyses were performed.
[RESULTS] PSM yielded 254 well-matched pairs (all p > 0.05). Average age (59.7 ± 11.3 vs. 59.3 ± 12.3 years) and BMI (32.1 ± 6.5 vs. 32.4 ± 6.6 kg/m) were similar between GVHR and NGVHR. Tobacco status was similar for current and former smokers (3.9% vs. 3.9%; 29.9% vs. 29.9%). GVHR had larger defect size (354.7 ± 132.1 vs. 103.8 ± 61.9 cm; p < 0.001) and mesh size (1161.9 ± 450.0 vs. 771.2 ± 388.4 cm; p < 0.001). In GVHR, Botulinum toxin injections (15.4% vs. 2.8%; p < 0.001) and component separation (50.6% vs. 23.7%; p < 0.001) were more frequent. Fascial defect was closed in 100% of both groups (p > 0.999). GVHR had higher rates of wound complications (33.5% vs. 15.4%; p < 0.001), respiratory insufficiency or failure (4.7% vs. 0.8%; p = 0.012), reoperation (9.8% vs. 4.7%; p = 0.028), and greater average length-of-stay (6.9 ± 5.1 vs. 5.0 ± 2.0 days; p < 0.001). There was no statistical difference in recurrence (4.3% vs. 2.4%; p = 0.217) or follow-up (24.0 ± 37.8 vs. 27.4 ± 40.4 months; p = 0.558).
[CONCLUSION] GVHR often required chemical and mechanical component separation to achieve fascial closure. However, with large preperitoneal mesh overlap and fascial closure, outcomes of large defects in VHR are comparable to smaller defects.
[METHODS] A prospectively-maintained database from a tertiary hernia center was reviewed for patients undergoing open VHR. 1:1 propensity-score matching was performed for GVHR versus NGVHR based on age, BMI, comorbidities, fascial defect closure, primary vs recurrent repair, CDC wound class, and ASA score. A multivariable regression model evaluated whether wound complications increased odds of recurrence. CDC class III/IV wounds and concomitant intraabdominal procedures were excluded. Standard statistical analyses were performed.
[RESULTS] PSM yielded 254 well-matched pairs (all p > 0.05). Average age (59.7 ± 11.3 vs. 59.3 ± 12.3 years) and BMI (32.1 ± 6.5 vs. 32.4 ± 6.6 kg/m) were similar between GVHR and NGVHR. Tobacco status was similar for current and former smokers (3.9% vs. 3.9%; 29.9% vs. 29.9%). GVHR had larger defect size (354.7 ± 132.1 vs. 103.8 ± 61.9 cm; p < 0.001) and mesh size (1161.9 ± 450.0 vs. 771.2 ± 388.4 cm; p < 0.001). In GVHR, Botulinum toxin injections (15.4% vs. 2.8%; p < 0.001) and component separation (50.6% vs. 23.7%; p < 0.001) were more frequent. Fascial defect was closed in 100% of both groups (p > 0.999). GVHR had higher rates of wound complications (33.5% vs. 15.4%; p < 0.001), respiratory insufficiency or failure (4.7% vs. 0.8%; p = 0.012), reoperation (9.8% vs. 4.7%; p = 0.028), and greater average length-of-stay (6.9 ± 5.1 vs. 5.0 ± 2.0 days; p < 0.001). There was no statistical difference in recurrence (4.3% vs. 2.4%; p = 0.217) or follow-up (24.0 ± 37.8 vs. 27.4 ± 40.4 months; p = 0.558).
[CONCLUSION] GVHR often required chemical and mechanical component separation to achieve fascial closure. However, with large preperitoneal mesh overlap and fascial closure, outcomes of large defects in VHR are comparable to smaller defects.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | fascial
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | wounds
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Ventral hernia repair
|
scispacy | 1 | ||
| 약물 | ASA
|
scispacy | 1 | ||
| 약물 | [RESULTS] PSM
|
scispacy | 1 | ||
| 질환 | hernia
|
C0019270
Hernia
|
scispacy | 1 | |
| 질환 | GVHR
→ giant" open VHR
|
scispacy | 1 | ||
| 질환 | HDS
→ hernia defect size
|
scispacy | 1 | ||
| 질환 | respiratory insufficiency
|
C0035229
Respiratory Insufficiency
|
scispacy | 1 | |
| 기타 | VHR
→ Ventral hernia repair
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | Tobacco
|
scispacy | 1 | ||
| 기타 | fascial
|
scispacy | 1 |
MeSH Terms
Humans; Hernia, Ventral; Herniorrhaphy; Middle Aged; Propensity Score; Male; Female; Treatment Outcome; Aged; Recurrence; Retrospective Studies; Postoperative Complications
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.